Self-reported Dermatological Problems and Preferences for Health: An Epidemiological Survey

Acta Dermato-Venereologica

Volumn 84, Issue 1, 2004, Pages 27-31

  Isacson, Dag ^a   Bingefors, Kerstin ^a   Lindberg, Magnus ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

Dermatology; Epidemiology; Rating scale; Skin disorders; Utilities

Indexed keywords

DERMATOLOGICAL AGENT;

ADULT; AGED; COMORBIDITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF REPORT; SKIN DISEASE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; SKIN DISEASES; SWEDEN;

EID: 0842285908     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310015491     Document Type: Review

References (35)

1. Williams H, Naldi L, Diepgen T. Epidemiology of skin disease in Europe, In: Fritsch P, ed. White book, dermatology in Europe. Bern: European Dermatology Forum, 2001: 5-15.
2. Williams H. Epidemiology of skin disease. In: Champion R, Burton J, Burns D, Bratnach S, eds. Textbook of dermatology. Oxford: Blackwell Science, 1998: 144-148.
3. Hellgren L. An epidemiological survey of skin diseases, Stockholm: Almquist & Wiksell, 1967.
4. Finlay A. Dowling Oration 2000. Dermatology patients: what do they really need? Clin Exp Dermatol 2000; 25: 444-450.
5. Finlay A. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-314.
6. Halioua B, Beumont M, Lunel F. Quality of life in dermatology. Int J Dermatol 2000; 39: 801-806.
7. Ware J, Sherbourne C. The MOS 36 item short form health survey (SF-36). Med Care 1992; 30: 473-483.
8. Nichol M, Margolies J, Lippa E, Rowe M, Quell J. The application of multiple Quality of Life instruments in individuals with mild to moderate psoriasis. Pharmaco-Economics 1996; 6: 644-653.
9. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80: 430-434.
10. Bingefors K, Lindberg M, Isacson D. Self-reported dermatological problems and use of prescription topical drugs correlate with decreased quality of life: an epidemiological survey. Br J Dermatol 2002; 147: 285-290.
11. Zug KA, Littenberg B, Baughman RD, Kneeland T, Nease RF, Sumner W, et al. Assessing the preferences of patients with psoriasis. A qualitative, utility approach. Arch Dermatol 1995; 131: 561-568.
12. Chen S, Shaheen A, Garber A. Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Arch Dermatol 1998; 134: 1602-1608.
13. Antonov K. Phamacoepidemiological studies on the use of analgesics in Sweden. PhD Thesis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, Uppsala: Acta Universitatis Upsaliensis, 1997.
14. Statistics Sweden. Living Conditions. Appendix 13. Technical report for 1984-85, 1986-87 and 1988-89 years Surveys of Living Conditions. Örebro: SCB-Tryck, 1991.
15. Statistics Sweden. Living Conditions. Report no. 76. Health and medical care 1980-1989, Örebro: SCB-Tryck, 1992.
16. Thorslund M, Wärneryd B. Methodological research in the Swedish Surveys of Living Conditions. Problems of measurments and data collection. Soc Ind Res 1985; 16: 77-95.
17. SAS Institute Inc The SAS system for windows, Release 6.12. Cary, NC, USA, 1996.
18. Picardi A, Abeni D, Melchi C, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
19. Hughes J, Barraclough B, Hamblin L, White J. Psychiatric symptoms in dermatology patients. Br J Psychol 1983; 143: 51-54.
20. Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998; 197: 230-234.
21. Gupta M, Gupta A. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol 2001; 15: 512-518.
22. Rea J, Newhouse M, Halil T. Skin disease in Lambeth: a community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30: 107-114.
23. Meding B. Normal standards for dermatological health screening at places of work. Contact Dermatitis 1992; 27: 269-270.
24. Hedberg A. An inquiry into relationship between body mass index and asthma: an analysis of data from two Swedish national registers. M.Sc. Thesis, Stockholm: Karolinska Institute, 1999.
25. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for economic evaluation of health care programmes, 2nd edn. Oxford, New York, Toronto: Oxford University Press, 1997.
26. Goossens M, Vlaeyen J, Rutten-van Mölken M, van der Linden S. Patient utilities in chronic musculoskeletal pain: how useful is the standard gamble method. Pain 1999; 80: 365-375.
27. Torrance G. Social preferences for health states. Socio-Economic Planning Sciences 1976; 10: 129-136.
28. Froberg D, Kane R. Methodology for measuring health-state preferences. I: Measurement strategies. J Clin Epidemiol 1989; 42: 345-354.
29. Sherbourne C, Unutzer J, Schoenbaum M, Duan N, Lenert L, Sturm R, et al. Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Med Care 2001; 39: 1246-1259.
30. Tsevat J, Keck PE, Hornung RW, McElroy SL. Health values of patients with bipolar disorder. Qual Life Res 2000; 9: 579-586.
31. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998; 80: 1989-1194.
32. Read J, Quin R, Berwick D, Fineberg H, Weinstein M. Preference for health outcomes: comparison of assessment methods. Med Decis Making 1984; 4: 315-329.
33. Bleichrodt H, Johannesson M. An experimental test of a theoretical foundation for rating scale valuations. Med Decis Making 1997; 17: 208-216.
34. Nord E. Cost-value analysis in health care. Cambridge: Cambridge University Press, 1999.
35. Bennet KJ, Torrance GW, Boyle MH, Guscott R, Morgan LA. Development and testing of a utility measure for major unipolar depression (McSad). Qual Life Res 2000; 9: 109-120.